Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction.

Authors

CM Tracy

Document Type

Journal Article

Publication Date

2011

Journal

Heart Rhythm

Volume

8

Issue

3

Inclusive Pages

401-402

This document is currently not available here.

Share

COinS